A comparative trial of hexamine hippurate and hexamine mandelate in prevention of recurrent infection of the urinary tract.
D000419:Albuminuria; D001416:Back Pain / Q000139:chemically induced; D002986:Clinical Trials as Topic; D003863:Depression / Q000139:chemically induced; D003967:Diarrhea / Q000139:chemically induced; D004063:Digestion / Q000187:drug effects; D004342:Drug Hypersensitivity; D004912:Erythrocytes; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D006417:Hematuria / Q000175:diagnosis; D006626:Hippurates / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007962:Leukocytes; D008333:Mandelic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D008709:Methenamine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced; D012008:Recurrence; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000517:prevention & control*; D014555:Urination Disorders / Q000139:chemically induced; D014556:Urine / Q000166:cytology; D014839:Vomiting / Q000139:chemically induced
D006626:Hippurates; D008333:Mandelic Acids; D008709:Methenamine